Roundtable: Adapting Sugar Reduction Strategies for the GLP-1 Era
Time: 3:30 pm
day: Conference Day One
Details:
The rise of GLP-1 agonists like Ozempic and Wegovy is already transforming eating habits, appetite, and food preferences, posing both challenges and opportunities for snacking & confectionary product lines. This session will explore how formulation strategies can evolve to meet the changing nutritional needs and consumption behaviors of this rapidly growing consumer segment.
Join peers from across the sector to discuss:
- How GLP-1 therapies are reshaping appetite and sugar consumption patterns
- Formulating low-sugar products that deliver satiety, nutritional density, and functional benefits for GLP1 patients
- Navigating the intersection of regulatory changes, public health goals, and commercial product development in the context of anti-obesity medications
